EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biology and Management of Acute Myeloid Leukemia With Mutated NPM1

Evan C Chen iD, Shai Shimony iD, Marlise R Luskin iD, Richard M Stone iD

American Journal of Hematology · 2025-04 · 100 (4) · 652-665

DOI: 10.1002/ajh.27600 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Hematology, online erschienen am 04.02.2025. Verfasst von Evan C Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Nuclear Proteins, Mutation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 121 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in nucleophosmin 1 ( NPM1 ) are diseased‐defining genetic alterations encountered in approximately one‐third of cases of acute myeloid leukemia (AML). A mutation in NPM1 confers a more favorable prognosis; however, clinical outcomes of NPM1 –mutated AML ( NPM1 mut AML) are diverse due to the heterogeneity of disease biology, patient characteristics, and treatment received. Research over the last two decades has dramatically expanded our understanding of the biology of NPM1 mut AML and led to the development of new therapeutic approaches and strategies for monitoring measurable residual disease (MRD). Here, we review NPM1 mut AML with a practical focus on the current treatment landscape, the role of MRD in guiding management, and emerging therapies, including menin inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteNuclear ProteinsMutationNucleophosminHumansNeoplasm, ResidualDisease ManagementProto-Oncogene Proteins

Stichwörter der Autor:innen

AMLAML‐molecular diagnosis & therapydysplasiasneoplasia‐myeloid leukemias

Substanzen

NucleophosminNPM1 protein, humanNuclear ProteinsProto-Oncogene Proteins

Autor:innen und Institutionen

  • Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

ORCID-Profile: Evan C Chen, Shai Shimony, Marlise R Luskin, Richard M Stone

Zitieren

APA

Chen, E. C., Shimony, S., Luskin, M. R., & Stone, R. M. (2025). Biology and Management of Acute Myeloid Leukemia With Mutated NPM1. American Journal of Hematology, 100(4), 652-665. https://doi.org/10.1002/ajh.27600

Vancouver

Chen EC, Shimony S, Luskin MR, Stone RM. Biology and Management of Acute Myeloid Leukemia With Mutated NPM1. American Journal of Hematology. 2025;100(4):652-665. doi:10.1002/ajh.27600

BibTeX
@article{Chen2025,
  author = {Chen, Evan C and Shimony, Shai and Luskin, Marlise R and Stone, Richard M},
  title = {Biology and Management of Acute Myeloid Leukemia With Mutated NPM1},
  journal = {American Journal of Hematology},
  year = {2025},
  volume = {100},
  number = {4},
  pages = {652--665},
  doi = {10.1002/ajh.27600}
}
Kostenlos starten →